13F-HR filed by Exome Asset Management LLC
Exome Asset Management LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 50 holding rows worth $114,847,122.
- Accession
- 0001420506-24-001571
- Filer
- CIK 2011932
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 50 entries on the cover page, a total value of $114,847,122 stated on the cover page (in dollars after the unit check, H1), rows summing to $114,847,122 with VALUE read as dollars as filed, 13F file number 028-23951. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 532457108 | COM | 9,700 | $8,782,186 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 74,000 | $6,791,730 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 32,900 | $5,198,200 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 251,600 | $4,475,964 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 496,635 | $4,406,264 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 12,200 | $4,032,954 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 84,790 | $3,836,748 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 56,800 | $3,805,600 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 11,800 | $3,686,910 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 443,379 | $3,644,576 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 10,800 | $3,025,728 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 209,092 | $2,939,834 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 25,928 | $2,939,716 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 839,472 | $2,921,362 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 6,358 | $2,828,356 | dollars as filed | |
| DR REDDYS LABS LTD ADR | 256135203 | ADR | 36,300 | $2,765,698 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 61,000 | $2,749,270 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 20,000 | $2,727,600 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 131,742 | $2,712,568 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 90,189 | $2,539,684 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 19,800 | $2,493,612 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 274,900 | $2,482,348 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 79,000 | $2,281,520 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 300,200 | $2,245,496 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 82,400 | $2,193,488 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 18,650 | $2,019,608 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 78,907 | $1,998,714 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 302,700 | $1,876,740 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 46,900 | $1,799,084 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 162,100 | $1,693,946 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 26,000 | $1,599,530 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 514,900 | $1,524,104 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 86,700 | $1,502,510 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 124,000 | $1,333,000 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 282,400 | $1,214,320 | dollars as filed | |
| ALVOTECH | L01800108 | ORDINARY SHARES | 99,000 | $1,203,840 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 1,127,699 | $1,015,944 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 369,322 | $997,170 | dollars as filed | |
| PROCAPS GROUP SA | L7756P102 | SHS | 129,301 | $877,428 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 159,175 | $821,344 | dollars as filed | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 59,650 | $787,976 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 43,865 | $787,376 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 353,434 | $696,264 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 358,400 | $580,608 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 137,174 | $558,298 | dollars as filed | |
| ADAGENE INC | 005329107 | CMN | 150,876 | $461,832 | dollars as filed | |
| NOVABRIDGE BIOSCIENCES | 44975P103 | CMN | 271,400 | $453,238 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 18,000 | $260,280 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 50,700 | $173,394 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 75,300 | $103,162 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-001571 | this filing | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001420506-24-002078 | base | 2024-10-03 | acceptance time not in the bulk data set |